Bioinformatics for cancer immunotherapy target discovery.

Lars Rønn Olsen, Benito Campos, Mike Stein Barnkob, Ole Winther, Vladimir Brusic, Mads Hald Andersen

    Research output: Contribution to journalJournal articleResearchpeer-review


    The mechanisms of immune response to cancer have been studied extensively and great effort has been invested into harnessing the therapeutic potential of the immune system. Immunotherapies have seen significant advances in the past 20 years, but the full potential of protective and therapeutic cancer immunotherapies has yet to be fulfilled. The insufficient efficacy of existing treatments can be attributed to a number of biological and technical issues. In this review, we detail the current limitations of immunotherapy target selection and design, and review computational methods to streamline therapy target discovery in a bioinformatics analysis pipeline. We describe specialized bioinformatics tools and databases for three main bottlenecks in immunotherapy target discovery: the cataloging of potentially antigenic proteins, the identification of potential HLA binders, and the selection epitopes and co-targets for single-epitope and multi-epitope strategies. We provide examples of application to the well-known tumor antigen HER2 and suggest bioinformatics methods to ameliorate therapy resistance and ensure efficient and lasting control of tumors.
    Original languageEnglish
    JournalCancer Immunology, Immunotherapy
    Issue number12
    Pages (from-to)1235-1249
    Publication statusPublished - 2014


    • HASH(0x3f3dc98)
    • Cancer vaccines
    • Tumor antigens
    • T cell epitopes
    • Biological databases
    • Computational biology


    Dive into the research topics of 'Bioinformatics for cancer immunotherapy target discovery.'. Together they form a unique fingerprint.

    Cite this